GaryMasonMD
Pediatric Hematology & Oncology • Spring House, PAPediatric Neuro-Oncology
Senior Medical Director, Oncology Janssen
Dr. Mason is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1400 McKean Road
Spring House, PA 19477
Education & Training
Children's National Medical Center/George Washington UniversityFellowship, Pediatric Neuro-Oncology, 2013 - 2014
New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology, 2010 - 2013
Brown UniversityResidency, Pediatrics, 2007 - 2010
Albert Einstein College of MedicineClass of 2007
Certifications & Licensure
PA State Medical License 2014 - 2024
DC State Medical License 2013 - 2014
NY State Medical License Active through 2013- American Board of Pediatrics Pediatrics
Clinical Trials
- Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors Start of enrollment: 2015 Jul 14
- Panobinostat in Treating Younger Patients With Progressive Diffuse Intrinsic Pontine Glioma Start of enrollment: 2016 Apr 01
Publications & Presentations
PubMed
- 532 citationsComprehensive Analysis of Hypermutation in Human CancerBrittany Campbell, Nicholas Light, David Fabrizio, Matthew Zatzman, Fabio Fuligni
Cell. 2017-11-16 - 98 citationsNiraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial.Matthew R Smith, Howard I Scher, Shahneen Sandhu, Eleni Efstathiou, Primo N Lara Jr
The Lancet. Oncology. 2022-03-01 - 30 citationsSurvival Benefit for Individuals With Constitutional Mismatch Repair Deficiency Undergoing Surveillance.Carol Durno, Ayse Bahar Ercan, Vanessa Bianchi, Melissa Edwards, Melyssa Aronson
Journal of Clinical Oncology. 2021-05-04
Journal Articles
- Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate CancerKim N Chi, Dana Rathkopf, Matthew R Smith, Eleni Efstathiou, Gerhardt Attard, David Olmos, Ji Youl Lee, Eric J Small, Andrea J Pereira de Santana Gomes, Guilhem Roubau..., J Clin Oncol ., 3/23/2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
